Kelajakdagi narxning foydaga nisbati: novointegrated.com (NVOS)

Novo Integrated Sciences, Inc. (NVOS) tovar belgisi

Novo Integrated Sciences (NVOS) kompaniyasining moliyaviy beqarorligi kapital tanqisligi hamda IT xizmatlarini tibbiyot bilan birlashtirishning murakkabliklari bilan bog'liq. Biznesning forward P/E ko'rsatkichi ushbu xatarlarni vizuallashtiradi, bunda 0.00 ushbu metrikaning so'nggi qiymatini aks ettiradi. Telemeditsina orqali kengayish va klinika tarmog'ining o'sishi rivojlanish yo'lini ochadi. Shu bilan birga, Medicare qoidalariga qat'iy rioya qilish va litsenziyalash talablari yangi ishtirokchilarga qarshi himoya to'sig'ini yaratadi.

Novo Integrated Sciences, Inc. - NVOS Kapitalizatsiyaning kelajakdagi foydaga nisbati (davr: 04.07.2022 - 16.11.2024)

Novo Integrated Sciences, Inc. (NVOS) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- kotirovkalar va tahlilchilar prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning umumiy tahlili:NVOS novointegrated.com
novointegrated.com brend mahsuloti

Novo Integrated Sciences (NVOS) klinikalari tarmog'ining hamyonbop profilaktika tibbiyotiga global talab fonida kengayishi kelajakdagi pul oqimlarini prognoz qilish uchun asos yaratadi. Joriy aksiya narxining kelgusi yil uchun kutilayotgan foydaga nisbati, kompaniyaning prognoz qilingan P/E ko'rsatkichi orqali aks etib, bozor narxining adolatli ekanligini baholash hamda investitsiya chegirmasini yoki yashirin tizimli inqiroz belgilarini o'z vaqtida aniqlash imkonini beradi.

Novo Integrated Sciences (NVOS) raqobatchilari

Kelajakdagi narxning foydaga nisbati HCA Holdings (HCA)|Tenet Healthcare - Narxning kelajakdagi foydaga nisbati|Fresenius Medical Care Corp - Prognoz qilingan narxning foydaga nisbati|SOLV: Narxning kelajakdagi foydaga nisbati|Encompass - Forvard P/E multiplikatori|UHS - Forvard P/E multiplikatori|DVA: Forvard P/E multiplikatori|RadNet Corp - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Option Care Health Inc|Forvard P/E multiplikatori surgerypartners.com|Forvard P/E multiplikatori PINC|Kapitalizatsiyaning prognoz qilingan foydaga nisbati National Vision Holdings, Inc.|Forvard P/E multiplikatori PGNY (Progyny Inc)|Ardent Health Corp (ARDT) - Prognoz qilingan narx-foyda nisbati|SEM: Prognoz qilingan narxning foydaga nisbati|ASTH - Forvard P/E multiplikatori|MD: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati USPH (US Physical Therapy)|Kelajakdagi narxning foydaga nisbati The Pennant Group, Inc.|ORGO - Forvard narx-foyda multiplikatori|Forvard P/E multiplikatori NUTX|Forvard P/E multiplikatori Auna (AUNA)|Forvard P/E multiplikatori SBC (sbc-holdings.com)|EOLS: Narxning kelajakdagi foydaga nisbati|Community Health Systems Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati The Beauty Health Company|MediWound Ltd (MDWD) - Kelajakdagi narxning foydaga nisbati|BTMD - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati The Joint|Prognoz qilingan narxning foydaga nisbati DocGo (DCGO)|P3 Health Partners, Inc. (PIII) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori Gain Therapeutics (GANX)|Forvard P/E multiplikatori EUDA (EUDA Health)|Kelajakdagi narx-foyda multiplikatori BMGL|CollPlant Ltd - Forvard P/E multiplikatori|Forvard narx-foyda multiplikatori Cuprina Holdings (Cayman) Ltd. (CUPR)|Concord Medical Corp (CCM) - Kelajakdagi narxning foydaga nisbati|ASHS - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati MEDIROM Healthcare Group|Forvard P/E multiplikatori avalon-globocare.com|Forvard P/E multiplikatori DHAI|XAGE (Carmell Therapeutics Corporation) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati NewGenIvf Corp NIVF|ATIP (atipt.com) - Narxning kutilayotgan foydaga nisbati|CareMax, Inc - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori KDLY (Kindly MD, Inc.)|MODV: Forvard P/E multiplikatori|SSY - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati IMAC Holdings Inc